MedPath

Therapeutic effect of thumbtack needle in the treatment of allergic rhinitis and its immune regulation of ILC-2 cells: a randomized controlled trial

Phase 1
Recruiting
Conditions
Allergic rhinitis
Registration Number
ITMCTR1900002391
Lead Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1 Meet the allergic rhinitis Chinese and western diagnostic criteria.
2 Aged 18 to 65 years, gender is not limited.
3 Sign the informed consent form and volunteer to participate in the study.
4 Participants can fill in the case report form and follow-up form by themselves.

Exclusion Criteria

1 Acute rhinitis (cold), vasomotor rhinitis, autonomic rhinitis, eosinophilic non-allergic rhinitis, allergic sinusitis.
2 Tape allergy history.
3 Local skin lesions such as burns, eczema, ulcers, frostbite ulceration.
4 During pregnancy and intent to pregnant women.
5 Due to intellectual or behavioral disorders, the test and investigators cannot be fully matched.
6 Participants who are lost to follow-up due to frequent changes in the working environment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
nasal symptom score;
Secondary Outcome Measures
NameTimeMethod
Rhinoconjunctivitis Quality of Life Questionnaire (Standard Edition);Changes in cytokines IL-33, IL-25 and TSLP;Visual simulation score sheet (10 points);Allergic rhinitis medical expenses;Drug usage record;
© Copyright 2025. All Rights Reserved by MedPath